Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis Bronchiectasis

Vodanovich, Domagoj; Bicknell, Thomas J; Holland, Anne E; Hill, Catherine J.; Cecins, Nola; Jenkins, Sue; McDonald, Christine F; Burge, Angela T; Thompson, Philip J.; Stirling, Robert; Lee, Annemarie L.

doi:10.1159/000430992

Cited by 17 publications

(12 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Chronic Respiratory Disease Questionnaire (CRDQ) consists of 20 items and assesses the domains of dyspnoea, fatigue, emotional function and mastery [113]. It was originally developed for use in COPD and has been validated in both COPD [114] and mild to moderate bronchiectasis [115]. The small study by THOMPSON et al [58] used the CRDQ and reported no health impact for individuals with bronchiectasis who completed 4 weeks of daily ACBT or Flutter.…”

Section: Chronic Respiratory Disease Questionnairementioning

confidence: 99%

Measuring airway clearance outcomes in bronchiectasis: a review

et al. 2020

View full text Add to dashboard Cite

While airway clearance techniques (ACTs) are recommended for individuals with bronchiectasis, many trials have demonstrated inconsistent benefits or failed to reach their primary outcome. This review determined the most common clinical and patient-reported outcome measures used to evaluate the efficacy of ACTs in bronchiectasis. A literature search of five databases using relevant keywords and filtering for studies published in English, up until the end of August 2019, was completed. Studies included randomised controlled trials, using crossover or any other trial design, and abstracts. Studies were included where the control was placebo, no intervention, standard care, usual care or an active comparator. Adults with bronchiectasis not related to cystic fibrosis were included. Extracted data comprised study authors, design, duration, intervention, outcome measures and results. The search identified 27 published studies and one abstract. The most common clinical outcome measures were sputum volume (n=23), lung function (n=17) and pulse oximetry (n=9). The most common patient-reported outcomes were health-related quality of life (measured with St George's Respiratory Questionnaire, n=4), cough-related quality of life (measured with Leicester Cough Questionnaire, n=4) and dyspnoea (measured with Borg/modified Borg scale, n=8). Sputum volume, lung function, dyspnoea and health- and cough-related quality of life appear to be the most common clinical and patient-reported measures of airway clearance treatment efficacy.

show abstract

Section: Chronic Respiratory Disease Questionnairementioning

confidence: 99%

Measuring airway clearance outcomes in bronchiectasis: a review

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Health‐related quality of life (HRQOL) was assessed using the 20‐item Chronic Respiratory Disease Questionnaire (CRQ). The questionnaire consists of dyspnea, fatigue, emotional function, and mastery subscores (Cronbach's α .82), 35 with higher scores indicating better HRQOL. The MCID for CRQ is 0.5 36 …”

Section: Methodsmentioning

confidence: 99%

Evaluating resilience as a predictor of outcomes in lung transplant candidates

Bui

Hathcock

Benzo

et al. 2020

Clinical Transplantation

View full text Add to dashboard Cite

Background Resilience represents the capacity to adapt to adversity. Resilience can improve following behavioral interventions. We examined lung transplant candidates’ resilience as a novel predictor using the Connor‐Davidson Resilience Scale (RISC‐10). Methods Waitlisted candidates at six centers were mailed questionnaires from 9/16/2015 to 10/1/2019. Follow‐up surveys were collected annually and post‐transplant. Outcomes were recorded through February 17, 2020. Primary outcome was pre‐transplant death/delisting. Analyses included t test or chi‐square for group comparisons, Pearson's correlation coefficients for strength of relationships, and Cox proportional‐hazard models to evaluate associations with outcomes, adjusting for age, sex, and mood. Results Participation was 55.3% (N = 199). Baseline RISC‐10 averaged 32.0 ± 5.6 and did not differ by demographics, primary transplant diagnosis, or disease severity markers. RISC‐10 did not correlate to the commonly utilized Psychosocial Assessment of Candidates for Transplant [PACT] or Stanford Integrated Psychosocial Assessment for Transplantation [SIPAT] tools. Scores < 26.3 (representing > 1 standard deviation below population average) occurred in 16% and were associated with pre‐transplant death or delisting, adjusted Hazard Ratio of 2.60 (95% Confidence Interval 1.23‐5.77; P = .01). Conclusion One in six lung candidates had low resilience, predicting increased pre‐transplant death/delisting. RISC‐10 did not correlate with PACT or SIPAT; resilience may represent a novel risk factor.

show abstract

“…The primary outcome will be change in CRQ dyspnea domain (CRQ-D) from baseline to end intervention. The CRQ-D is a valid measure of HRQoL and is responsive to change with pulmonary rehabilitation in people with chronic respiratory diseases including COPD [ 40 ], bronchiectasis [ 41 ] and ILD [ 42 ].…”

Section: Methodsmentioning

confidence: 99%

Telerehabilitation versus traditional centre-based pulmonary rehabilitation for people with chronic respiratory disease: protocol for a randomised controlled trial

et al. 2018

Self Cite

View full text Add to dashboard Cite

BackgroundPulmonary rehabilitation is an effective therapeutic intervention for people with chronic respiratory disease. However, fewer than 5% of eligible individuals receive pulmonary rehabilitation on an annual basis, largely due to limited availability of services and difficulties associated with travel and transport. The Rehabilitation Exercise At Home (REAcH) study is an assessor-blinded, multi-centre, randomised controlled equivalence trial designed to compare the efficacy of home-based telerehabilitation and traditional centre-based pulmonary rehabilitation in people with chronic respiratory disease.MethodsParticipants will undertake an 8-week group-based pulmonary rehabilitation program of twice-weekly supervised exercise training, either in-person at a centre-based pulmonary rehabilitation program or remotely from their home via the Internet. Supervised exercise training sessions will include 30 min of aerobic exercise (cycle and/or walking training). Individualised education and self-management training will be delivered. All participants will be prescribed a home exercise program of walking and strengthening activities.Outcomes will be assessed by a blinded assessor at baseline, after completion of the intervention, and 12-months post intervention. The primary outcome is change in dyspnea score as measured by the Chronic Respiratory Questionnaire – dyspnea domain (CRQ-D). Secondary outcomes will evaluate the efficacy of telerehabilitation on 6-min walk distance, endurance cycle time during a constant work rate test, physical activity and quality of life. Adherence to pulmonary rehabilitation between the two models will be compared. A full economic analysis from a societal perspective will be undertaken to determine the cost-effectiveness of telerehabilitation compared to centre-based pulmonary rehabilitation.DiscussionAlternative models of pulmonary rehabilitation are required to improve both equity of access and patient-related outcomes. This trial will establish whether telerehabilitation can achieve equivalent improvement in outcomes compared to traditional centre-based pulmonary rehabilitation. If efficacious and cost-effective, the proposed telerehabilitation model is designed to be rapidly deployed into clinical practice.Trial registrationClinical trial registered with the Australian and New Zealand Clinical Trials Register at (ACTRN12616000360415). Registered 21 March 2016.

show abstract

Validity and Reliability of the Chronic Respiratory Disease Questionnaire in Elderly Individuals with Mild to Moderate Non-Cystic Fibrosis Bronchiectasis

Cited by 17 publications

References 53 publications

Measuring airway clearance outcomes in bronchiectasis: a review

Measuring airway clearance outcomes in bronchiectasis: a review

Evaluating resilience as a predictor of outcomes in lung transplant candidates

Telerehabilitation versus traditional centre-based pulmonary rehabilitation for people with chronic respiratory disease: protocol for a randomised controlled trial

Contact Info

Product

Resources

About